Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides

ACS Chemical Biology

Volumn 9, Issue 7, 2014, Pages 1613-1621

  Lee, Myung Ryul ^a   Raman, Namrata ^a   Gellman, Samuel H ^b   Lynn, David M ^a,b   Palecek, Sean P ^a  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG STRUCTURE; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; CANDIDIASIS; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; PROTEIN SECONDARY STRUCTURE;

ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CANDIDA ALBICANS; CANDIDIASIS; DRUG DESIGN; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY;

EID: 84904578022     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500203e     Document Type: Article

References (84)

1. Mavor, A. L., Thewes, S., and Hube, B. (2005) Systemic fungal infections caused by Candida species: Epidemiology, infection process and virulence attributes Curr. Drug Targets 6, 863-874 (Pubitemid 41672448)
2. Brown, G. D., Denning, D. W., and Levitz, S. M. (2012) Tackling human fungal infections Science 336, 647-647
3. Fishman, J. A. (2007) Infection in solid-organ transplant recipients N. Engl. J. Med. 357, 2601-2614 (Pubitemid 350294226)
4. Fridkin, S. K., Kaufman, D., Edwards, J. R., Shetty, S., and Horan, T. (2006) Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004 Pediatrics 117, 1680-1687 (Pubitemid 46071397)
5. Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., Brumble, L. M., Freifeld, A. G., Hadley, S., Herwaldt, L. A., Kauffman, C. A., Knapp, K., Lyon, G. M., Morrison, V. A., Papanicolaou, G., Patterson, T. F., Perl, T. M., Schuster, M. G., Walker, R., Wannemuehler, K. A., Wingard, J. R., Chiller, T. M., and Pappas, P. G. (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the transplant-associated infection surveillance network (TRANSNET) database Clin. Infect. Dis. 50, 1091-1100
6. Neofytos, D., Fishman, J. A., Horn, D., Anaissie, E., Chang, C. H., Olyaei, A., Pfaller, M., Steinbach, W. J., Webster, K. M., and Marr, K. A. (2010) Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients Transpl. Infect. Dis. 12, 220-229
7. Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., and Marr, K. (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of multicenter prospective antifungal therapy (PATH) alliance registry Clin. Infect. Dis. 48, 265-273
8. Singh, N. (2003) Fungal infections in the recipients of solid organ transplantation Infect. Dis. Clin. North Am. 17, 113-134 (Pubitemid 36514573)
9. Jabra-Rizk, M. A., Johnson, J. K., Forrest, G., Mankes, K., Meiller, T. F., and Venezia, R. A. (2005) Prevalence of Candida dubliniensis fungemia at a large teaching hospital Clin. Infect. Dis. 41, 1064-1067 (Pubitemid 41368235)
10. Walsh, T. J. and Groll, A. H. (1999) Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century Transpl. Infect. Dis. 1, 247-261
11. Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., Horowitz, H. W., Edwards, J. E., and Dismukes, W. E. (2003) NAIAD Mycoses Study Group, A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients Clin. Infect. Dis. 37, 634-643 (Pubitemid 37100802)
12. Mukherjee, P. K., Zhou, G. Y., Munyon, R., and Ghannoum, M. A. (2005) Candida biofilm: A well-designed protected environment Med. Mycol. 43, 191-208 (Pubitemid 40867493)
13. Kojic, E. M. and Darouiche, R. O. (2004) Candida infections of medical devices Clin. Microbiol. Rev. 17, 255-267 (Pubitemid 38534029)
14. Hawser, S. P. and Douglas, L. J. (1995) Resistance of Candida-albicans biofilms to antifungal agents in-vitro Antimicrob. Agents Chemother. 39, 2128-2131
15. Ganz, T. (2003) Defensins: Antimicrobial peptides of innate immunity Nat. Rev. Immunol. 3, 710-720 (Pubitemid 41070812)
16. Gallo, R. L. and Nizet, V. (2003) Endogenous production of antimicrobial peptides in innate immunity and human disease Curr. Allergy Asthma Rep. 3, 402-409 (Pubitemid 38899107)
17. Beutler, B. (2004) Innate immunity: an overview Mol. Immunol. 40, 845-859 (Pubitemid 38035204)
18. Hancock, R. E. W. and Lehrer, R. (1998) Cationic peptides: a new source of antibiotics Trends Biotechnol. 16, 82-88 (Pubitemid 28055477)
19. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms Nature 415, 389-395 (Pubitemid 34100944)
20. Brogden, K. A., Ackermann, M., McCray, P. B., and Tack, B. F. (2003) Antimicrobial peptides in animals and their role in host defences Int. J. Antimicrob. Agents 22, 465-478 (Pubitemid 37356946)
21. Antimicrobial Peptide Database (http://aps.unmc.edu/AP/main.php).
22. Chu, H. L., Yu, H. Y., Yip, B. S., Chih, Y. H., Liang, C. W., Cheng, H. T., and Cheng, J. W. (2013) Boosting salt resistance of short antimicrobial peptides Antimicrob. Agents Chemother. 57, 4050-4052
23. Smith, J. J., Travis, S. M., Greenberg, E. P., and Welsh, M. J. (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85, 229-236 (Pubitemid 26118164)
24. Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., and Hancock, R. E. W. (2005) Impact of LL-37 on anti-infective immunity J. Leukocyte Biol. 77, 451-459 (Pubitemid 40489520)
25. Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., and Wilson, J. M. (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis Cell 88, 553-560 (Pubitemid 27154420)
26. Huang, J. F., Hao, D. M., Chen, Y., Xu, Y. M., Tan, J. J., Huang, Y. B., Li, F., and Chen, Y. X. (2011) Inhibitory effects and mechanisms of physiological conditions on the activity of enantiomeric forms of an alpha-helical antibacterial peptide against bacteria Peptides 32, 1488-1495
27. Yeaman, M. R. and Yount, N. Y. (2003) Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55, 27-55 (Pubitemid 36268398)
28. Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides Biochim. Biophys. Acta, Biomembr. 1462, 55-70
29. Huang, H. W. (2000) Action of antimicrobial peptides: Two-state model Biochemistry 39, 8347-8352 (Pubitemid 30489931)
30. Nizet, V. (2006) Antimicrobial peptide resistance mechanisms of human bacterial pathogens Curr. Issues Mol. Biol. 8, 11-26 (Pubitemid 43141388)
31. Schmidtchen, A., Frick, I. M., Andersson, E., Tapper, H., and Bjorck, L. (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37 Mol. Microbiol. 46, 157-168 (Pubitemid 35238020)
32. Andersson, D. I. and Hughes, D. (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260-271
33. Brogden, K. A. (2005) Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250 (Pubitemid 40298223)
34. Hilchie, A. L., Wuerth, K., and Hancock, R. E. W. (2013) Immune modulation by multifaceted cationic host defense (antimicrobial) peptides Nat. Chem. Biol. 9, 761-768
35. Padhee, S., Hu, Y. G., Niu, Y. H., Bai, G., Wu, H. F., Costanza, F., West, L., Harrington, L., Shaw, L. N., Cao, C. H., and Cai, J. F. (2011) Non-hemolytic alpha-AApeptides as antimicrobial peptidomimetics Chem. Commun. 47, 9729-9731
36. Chongsiriwatana, N. P., Miller, T. M., Wetzler, M., Vakulenko, S., Karlsson, A. J., Palecek, S. P., Mobashery, S., and Barron, A. E. (2011) Short alkylated peptoid mimics of antimicrobial lipopeptides Antimicrob. Agents Chemother. 55, 417-420
37. Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., and Barron, A. E. (2008) Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides Proc. Natl. Acad. Sci. U.S.A. 105, 2794-2799 (Pubitemid 351723623)
38. Ryge, T. S. and Hansen, P. R. (2005) Novel lysine-peptoid hybrids with antibacterial properties J. Pept. Sci. 11, 727-734 (Pubitemid 41684259)
39. Ivankin, A., Livne, L., Mor, A., Caputo, G. A., DeGrado, W. F., Meron, M., Lin, B., and Gidalevitz, D. (2010) Role of the conformational rigidity in the design of biomimetic antimicrobial compounds Angew. Chem., Int. Ed. 49, 8462-8465
40. Scott, R. W., DeGrado, W. F., and Tew, G. N. (2008) De novo designed synthetic mimics of antimicrobial peptides Curr. Opin. Biotechnol. 19, 620-627
41. Claudon, P., Violette, A., Lamour, K., Decossas, M., Fournel, S., Heurtault, B., Godet, J., Mely, Y., Jamart-Gregoire, B., Averlant-Petit, M. C., Briand, J. P., Duportail, G., Monteil, H., and Guichard, G. (2010) Consequences of isostructural main-chain modifications for the design of antimicrobial foldamers: Helical mimics of host-defense peptides based on a heterogeneous amide/urea backbone Angew. Chem., Int. Ed. 49, 333-336
42. Liu, R. H., Chen, X. Y., Falk, S. P., Mowery, B. P., Karlsson, A. J., Weisblum, B., Palecek, S. P., Masters, K. S., and Gellman, S. H. (2014) Structure-activity relationships among antifungal nylon-3 polymers: Identification of materials active against drug-resistant strains of Candida albicans J. Am. Chem. Soc. 136, 4333-4342
43. Takahashi, H., Palermo, E. F., Yasuhara, K., Caputo, G. A., and Kuroda, K. (2013) Molecular design, structures, and activity of antimicrobial peptide-mimetic polymers Macromol. Biosci. 13, 1285-1299
44. Uppu, D., Akkapeddi, P., Manjunath, G. B., Yarlagadda, V., Hoque, J., and Haldar, J. (2013) Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents Chem. Commun. 49, 9389-9391
45. Oda, Y., Kanaoka, S., Sato, T., Aoshima, S., and Kuroda, K. (2011) Block versus random amphiphilic copolymers as antibacterial agents Biomacromolecules 12, 3581-3591
46. Kuroda, K. and DeGrado, W. F. (2005) Amphiphilic polymethacrylate derivatives as antimicrobial agents J. Am. Chem. Soc. 127, 4128-4129 (Pubitemid 40463011)
47. Tew, G. N., Liu, D. H., Chen, B., Doerksen, R. J., Kaplan, J., Carroll, P. J., Klein, M. L., and DeGrado, W. F. (2002) De novo design of biomimetic antimicrobial polymers Proc. Natl. Acad. Sci. U.S.A. 99, 5110-5114 (Pubitemid 34411511)
48. Epand, R. F., Schmitt, M. A., Gellman, S. H., and Epand, R. M. (2006) Role. of membrane lipids in the mechanism of bacterial species selective toxicity by two alpha/beta-antimicrobial peptides Biochim. Biophys. Acta, Biomembr. 1758, 1343-1350 (Pubitemid 44436066)
49. Epand, R. F., Schmitt, M. A., Gellman, S. H., Sen, A., Auger, M., Hughes, D. W., and Epand, R. M. (2005) Bacterial species selective toxicity of two isomeric alpha/beta-peptides: Role of membrane lipids Mol. Membr. Biol. 22, 457-469 (Pubitemid 43030902)
50. Seebach, D. and Matthews, J. L. (1997) Beta-peptides: a surprise at every turn Chem. Commun. 2015-2022
51. Cheng, R. P., Gellman, S. H., and DeGrado, W. F. (2001) Beta-peptides: From structure to function Chem. Rev. 101, 3219-3232
52. Hintermann, T. and Seebach, D. (1997) The biological stability of beta-peptides: No interactions between alpha- and beta-peptidic structures Chimia 51, 244-247 (Pubitemid 127386096)
53. Raguse, T. L., Porter, E. A., Weisblum, B., and Gellman, S. H. (2002) Structure-activity studies of 14-helical antimicrobial beta-peptides: Probing the relationship between conformational stability and antimicrobial potency J. Am. Chem. Soc. 124, 12774-12785 (Pubitemid 35216001)
54. Liu, D. H. and DeGrado, W. F. (2001) De novo design, synthesis, and characterization of antimicrobial beta-peptides J. Am. Chem. Soc. 123, 7553-7559
55. Hamuro, Y., Schneider, J. P., and DeGrado, W. F. (1999) De novo design of antibacterial beta-peptides J. Am. Chem. Soc. 121, 12200-12201
56. Arvidsson, P. I., Frackenpohl, J., Ryder, N. S., Liechty, B., Petersen, F., Zimmermann, H., Camenisch, G. P., Woessner, R., and Seebach, D. (2001) On the antimicrobial and hemolytic activities of amphiphilic beta-peptides ChemBioChem 2, 771-773 (Pubitemid 33722632)
57. Karlsson, A. J., Pomerantz, W. C., Neilsen, K. J., Gellman, S. H., and Palecek, S. P. (2009) Effect of sequence and structural properties on 14-helical beta-peptide activity against Candida albicans planktonic cells and biofilms ACS Chem. Biol. 4, 567-579
58. Karlsson, A. J., Pomerantz, W. C., Weisblum, B., Gellman, S. H., and Palecek, S. P. (2006) Antifungal activity from 14-helical beta-peptides J. Am. Chem. Soc. 128, 12630-12631
59. Epand, R. F., Umezawa, N., Porter, E. A., Gellman, S. H., and Epand, R. M. (2003) Interactions of the antimicrobial beta-peptide beta-17 with phospholipid vesicles differ from membrane interactions of magainins Eur. J. Biochem. 270, 1240-1248 (Pubitemid 36384456)
60. Porter, E. A., Weisblum, B., and Gellman, S. H. (2002) Mimicry of host-defense peptides by unnatural oligomers: Antimicrobial beta-peptides J. Am. Chem. Soc. 124, 7324-7330 (Pubitemid 34670441)
61. Porter, E. A., Wang, X. F., Lee, H. S., Weisblum, B., and Gellman, S. H. (2000) Antibiotics-Non-haemolytic beta-amino-acid oligomers Nature 404, 565-565
62. Arvidsson, P. I., Ryder, N. S., Weiss, H. M., Gross, G., Kretz, O., Woessner, R., and Seebach, D. (2003) Antibiotic and hemolytic activity of a beta(2)/beta(3) peptide capable of folding into a 12/10-helical secondary structure ChemBioChem 4, 1345-1347 (Pubitemid 38036417)
63. Parker, J. M. R., Guo, D., and Hodges, R. S. (1986) New hydrophiliity scale derived from high-performance liquid-chromatography peptide retention data-correlation of predicted surface residues with antigenicity and x-ray derived accessible sites Biochemistry 25, 5425-5432
64. Browne, C. A., Bennett, H. P. J., and Solomon, S. (1982) The isolation of peptides by high-performance liquid-chromatography using predicted elution positions Anal. Biochem. 124, 201-208 (Pubitemid 13250026)
65. Wilson, K. J., Honegger, A., Stotzel, R. P., and Hughes, G. J. (1981) The behavior of peptides on reverse-phase supports during high-pressure liquid-chromatorraphy Biochem. J. 199, 31-41
66. Kondejewski, L. H., Jelokhani-Niaraki, M., Farmer, S. W., Lix, B., Kay, C. M., Sykes, B. D., Hancock, R. E. W., and Hodges, R. S. (1999) Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity J. Biol. Chem. 274, 13181-13192
67. Kim, S., Kim, S. S., and Lee, B. J. (2005) Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times Peptides 26, 2050-2056 (Pubitemid 41584066)
68. Jiang, Z. Q., Kullberg, B. J., van der Lee, H., Vasil, A. I., Hale, J. D., Mant, C. T., Hancock, R. E. W., Vasil, M. L., Netea, M. G., and Hodges, R. S. (2008) Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides Chem. Biol. Drug Des. 72, 483-495
69. Zasloff, M. (1987) Magainins, a class of antimicrobial peptides from xenopus skin-isolation, characterization of two active forms, and partial cDNA sequence of a precursor Proc. Natl. Acad. Sci. U.S.A. 84, 5449-5453 (Pubitemid 17129018)
70. Rosetto, M., Manetti, A. G. O., Marchini, D., Dallai, R., Telford, J. L., and Baldari, C. T. (1993) Sequences of two cDNA clones from the medfly ceratitis-capitata encoding antibacterial peptides of the ceropin family Gene 134, 241-243
71. Mor, A. and Nicolas, P. (1994) Isolation and structure of novel defensive pepptides from frog-skin Eur. J. Biochem. 219, 145-154 (Pubitemid 24053627)
72. Kreil, G. (1973) Structure of melittin isolated from two species of honey bees FEBS Lett. 33, 241-244
73. Bagella, L., Scocchi, M., and Zanetti, M. (1995) cDNA sequences of three sheep myeloid cathelicidins FEBS Lett. 376, 225-228
74. Duvick, J. P., Rood, T., Rao, A. G., and Marshak, D. R. (1992) Purification and characterization of a novel antimicrobial peptide from maize(Zea-mays L.) kernels J. Biol. Chem. 267, 18814-18820
75. Rasul, R., Cole, N., Balasubramanian, D., Chen, R., Kumar, N., and Willcox, M. D. P. (2010) Interaction of the antimicrobial peptide melimine with bacterial membranes Int. J. Antimicrob. Agents 35, 566-572
76. Wieprecht, T., Dathe, M., Beyermann, M., Krause, E., Maloy, W. L., MacDonald, D. L., and Bienert, M. (1997) Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes Biochemistry 36, 6124-6132 (Pubitemid 27257879)
77. Chen, Y. X., Vasil, A. I., Rehaume, L., Mant, C. T., Burns, J. L., Vasil, M. L., Hancock, R. E. W., and Hodges, R. S. (2006) Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides Chem. Biol. Drug Des. 67, 162-173 (Pubitemid 43881376)
78. Chen, Y. X., Mant, C. T., Farmer, S. W., Hancock, R. E. W., Vasil, M. L., and Hodges, R. S. (2005) Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index J. Biol. Chem. 280, 12316-12329
79. Chen, H. C., Brown, J. H., Morell, J. L., and Huang, C. M. (1988) Synthetic magainin analogs with improved antimicrobial activity FEBS Lett. 236, 462-466
80. Zhang, L. J., Benz, R., and Hancock, R. E. W. (1999) Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides Biochemistry 38, 8102-8111
81. Grieco, P., Carotenuto, A., Auriemma, L., Saviello, M. R., Campiglia, P., Gomez-Monterrey, I. M., Marcellini, L., Luca, V., Barra, D., Novellino, E., and Mangoni, M. L. (2013) The effect of D-amino acid substitution on the selectivity of temporin L towards target cells: Identification of a potent anti-Candida peptide Biochim. Biophys. Acta, Biomembr. 1828, 652-660
82. Murray, J. K. and Gellman, S. H. (2005) Application of microwave irradiation to the synthesis of 14-helical beta-peptides Org. Lett. 7, 1517-1520 (Pubitemid 40585920)
83. National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard, 2 nd ed., NCCL document M27-A2, NCCLS, Wayne, PA.
84. Daniels, D. S., Petersson, E. J., Qiu, J. X., and Schepartz, A. (2007) High-resolution structure of a beta-peptide bundle J. Am. Chem. Soc. 129, 1532-1533